2nd Annual Cancer Immunotherapy Summit
July 10, 2017Advanced methods in Cancer Immunotherapy
X
2nd Annual Cancer Immunotherapy Summit
https://pharmaphorum.com/events/2nd-annual-cancer-immunotherapy-summit/
immunotherapy
Immuno-oncology drugs: key to the Cancer Moonshot?
June 21, 2017Assessing the global challenges inhibiting immuno-oncology market access.
Top 5 challenges of immuno-oncology clinical trials
June 7, 2017Learn innovative solutions to address these challenges
Managing Multi-Arm Studies in an Evolving Immuno-Oncology Landscape
June 7, 2017Collaborate with CROs and sites to help minimize risks
Merck KGaA to develop immunotherapies with F-star
June 6, 2017German Merck has option to licence LAG3-PDL1 drug.
The cancer challenge: the quest for a cure is only half the battle
May 18, 2017The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.
Takeda signs deal with UK biotech GammaDelta Therapeutics on T cell therapy
May 10, 2017UK biotech pioneering new type of T cell immunotherapy
Deep Dive: Oncology magazine launched today
May 9, 2017Are cancer screening and diagnosis swift enough, and how effective are the latest tailored drugs?
